Submission Details
| 510(k) Number | K883714 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 1988 |
| Decision Date | October 19, 1988 |
| Days to Decision | 50 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K883714 is an FDA 510(k) clearance for the QM300 APOLIPOPROTEIN B ANTIBODY PACK, a Apolipoproteins (Class I — General Controls, product code MSJ), submitted by Kallestad Diag, A Div. of Erbamont, Inc. (Chaska, US). The FDA issued a Cleared decision on October 19, 1988, 50 days after receiving the submission on August 30, 1988. This device falls under the Immunology review panel. Regulated under 21 CFR 862.1475.
| 510(k) Number | K883714 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 1988 |
| Decision Date | October 19, 1988 |
| Days to Decision | 50 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | MSJ — Apolipoproteins |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1475 |